Treatment.com International (TSE:TRUE) has released an update.
Restart Life Sciences Corp, a Canadian life sciences company, has successfully completed a debt settlement transaction, exchanging over 6.3 million common shares to settle approximately CDN$318,000 in debt. This transaction includes a related party component, where shares were issued to settle debts owed for unpaid fees and loans.
For further insights into TSE:TRUE stock, check out TipRanks’ Stock Analysis page.